Revenue Summary of Boiron SA

Boiron SA's latest annual revenue in 2023 was 493.24 Million EUR , down -7.67% from previous year.
Boiron SA's latest quarterly revenue in 2024 Q2 was 228.34 Million EUR , down 0.0% from previous quarter.
Boiron SA reported a annual revenue of 534.23 Million EUR in annual revenue 2022, up 17.36% from previous year.
Boiron SA reported a annual revenue of 455.2 Million EUR in annual revenue 2021, down -11.37% from previous year.
Boiron SA reported a quarterly revenue of 239.88 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Boiron SA reported a quarterly revenue of 253.36 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Boiron SA (2023 - 2001)

Historical Annual Revenue of Boiron SA (2023 - 2001)

Year	Revenue	Revenue Growth
2023	493.24 Million EUR	-7.67%
2022	534.23 Million EUR	17.36%
2021	455.2 Million EUR	-11.37%
2020	513.58 Million EUR	-7.82%
2019	557.12 Million EUR	-7.79%
2018	604.21 Million EUR	-2.16%
2017	617.54 Million EUR	0.5%
2016	614.49 Million EUR	1.07%
2015	607.96 Million EUR	-0.33%
2014	609.98 Million EUR	-1.3%
2013	617.98 Million EUR	9.13%
2012	566.29 Million EUR	8.18%
2011	523.45 Million EUR	0.55%
2010	520.6 Million EUR	-1.08%
2009	526.27 Million EUR	12.72%
2008	466.89 Million EUR	7.46%
2007	434.47 Million EUR	8.98%
2006	398.67 Million EUR	10.24%
2005	361.64 Million EUR	24.43%
2004	290.63 Million EUR	-4.82%
2003	305.33 Million EUR	6.37%
2002	287.05 Million EUR	7.76%
2001	266.38 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	228.34 Million EUR	0.0%
2023 Q2	239.88 Million EUR	0.0%
2023 Q4	253.36 Million EUR	0.0%
2023 FY	493.24 Million EUR	-7.67%
2022 Q2	256.76 Million EUR	0.0%
2022 Q4	277.47 Million EUR	0.0%
2022 FY	534.23 Million EUR	17.36%
2021 FY	455.2 Million EUR	-11.37%
2021 Q4	265.26 Million EUR	0.0%
2021 Q2	189.93 Million EUR	0.0%
2020 Q2	253.63 Million EUR	0.0%
2020 Q4	259.94 Million EUR	0.0%
2020 FY	513.58 Million EUR	-7.82%
2019 FY	557.12 Million EUR	-7.79%
2019 Q4	300.4 Million EUR	0.0%
2019 Q2	256.71 Million EUR	0.0%
2018 Q2	280.53 Million EUR	0.0%
2018 FY	604.21 Million EUR	-2.16%
2018 Q4	323.68 Million EUR	0.0%
2017 Q2	284.66 Million EUR	0.0%
2017 Q4	332.87 Million EUR	0.0%
2017 FY	617.54 Million EUR	0.5%
2016 FY	614.49 Million EUR	1.07%
2016 Q2	284.3 Million EUR	0.0%
2016 Q4	330.18 Million EUR	0.0%
2015 Q4	332.31 Million EUR	0.0%
2015 Q2	275.64 Million EUR	0.0%
2015 FY	607.96 Million EUR	-0.33%
2014 Q2	261.79 Million EUR	0.0%
2014 FY	609.98 Million EUR	-1.3%
2014 Q4	348.19 Million EUR	0.0%
2013 Q2	275.92 Million EUR	0.0%
2013 FY	617.98 Million EUR	9.13%
2013 Q4	342.06 Million EUR	0.0%
2012 Q2	141.64 Million EUR	0.0%
2012 FY	566.29 Million EUR	8.18%
2012 Q1	141.64 Million EUR	0.0%
2012 Q3	141.64 Million EUR	0.0%
2012 Q4	154.49 Million EUR	9.07%
2011 Q2	130.86 Million EUR	0.0%
2011 FY	523.45 Million EUR	0.55%
2011 Q4	141.64 Million EUR	8.24%
2011 Q1	130.86 Million EUR	0.0%
2011 Q3	130.86 Million EUR	0.0%
2010 Q2	130.15 Million EUR	0.0%
2010 FY	520.6 Million EUR	-1.08%
2010 Q4	130.86 Million EUR	0.55%
2010 Q3	130.15 Million EUR	0.0%
2010 Q1	130.15 Million EUR	0.0%
2009 Q2	131.56 Million EUR	0.0%
2009 Q3	131.56 Million EUR	0.0%
2009 Q4	130.15 Million EUR	-1.08%
2009 FY	526.27 Million EUR	12.72%
2009 Q1	131.56 Million EUR	0.0%
2008 FY	466.89 Million EUR	7.46%
2008 Q4	131.56 Million EUR	12.72%
2008 Q3	116.72 Million EUR	0.0%
2008 Q2	116.72 Million EUR	0.0%
2008 Q1	116.72 Million EUR	0.0%
2007 Q3	108.61 Million EUR	0.0%
2007 Q2	108.61 Million EUR	0.0%
2007 Q1	108.61 Million EUR	0.0%
2007 Q4	116.72 Million EUR	7.46%
2007 FY	434.47 Million EUR	8.98%
2006 Q4	108.61 Million EUR	8.98%
2006 Q3	99.66 Million EUR	0.0%
2006 Q2	99.66 Million EUR	0.0%
2006 Q1	99.66 Million EUR	0.0%
2006 FY	398.67 Million EUR	10.24%
2005 FY	361.64 Million EUR	24.43%
2005 Q4	99.66 Million EUR	10.24%
2005 Q3	90.41 Million EUR	0.0%
2005 Q2	90.41 Million EUR	0.0%
2005 Q1	90.41 Million EUR	0.0%
2004 FY	290.63 Million EUR	-4.82%
2004 Q4	90.41 Million EUR	24.43%
2004 Q3	72.65 Million EUR	0.0%
2004 Q2	72.65 Million EUR	0.0%
2004 Q1	72.65 Million EUR	0.0%
2003 Q4	72.65 Million EUR	-4.82%
2003 FY	305.33 Million EUR	6.37%
2003 Q3	76.33 Million EUR	0.0%
2003 Q2	76.33 Million EUR	0.0%
2003 Q1	76.33 Million EUR	0.0%
2002 Q1	71.76 Million EUR	0.0%
2002 FY	287.05 Million EUR	7.76%
2002 Q4	76.33 Million EUR	6.37%
2002 Q3	71.76 Million EUR	0.0%
2002 Q2	71.76 Million EUR	0.0%
2001 FY	266.38 Million EUR	0.0%
2001 Q1	66.59 Million EUR	0.0%
2001 Q2	66.59 Million EUR	0.0%
2001 Q3	66.59 Million EUR	0.0%
2001 Q4	71.76 Million EUR	7.76%
2000 Q4	66.59 Million EUR	0.0%

Peer Revenue Comparison of Boiron SA

Name	Revenue	Revenue Difference
Laboratorios Farmaceuticos Rovi, S.A.	829.5 Million EUR	40.537%
Vetoquinol SA	529.27 Million EUR	6.806%
Valneva SE	153.71 Million EUR	-220.891%
AB Science S.A.	970 Thousand EUR	-50750.309%
Nanobiotix S.A.	30.05 Million EUR	-1540.987%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-37098.19%
Vivoryon Therapeutics N.V.	-3.62 Million EUR	13725.635%
BioSenic S.A.	543 Thousand EUR	-90737.569%
ABIVAX Société Anonyme	4.62 Million EUR	-10574.053%
Formycon AG	77.69 Million EUR	-534.843%

Global Stocks Search

Boiron SA (0DTF.L)

Revenue Summary of Boiron SA

Annual Revenue Chart of Boiron SA (2023 - 2001)

Historical Annual Revenue of Boiron SA (2023 - 2001)

Peer Revenue Comparison of Boiron SA